International Journal of Personalized Medicine

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

International Journal of Personalized Medicine-Rare diseases-Bridget Bax

United Kingdom

St George's University of London.

Send an Email

Bridget Bax


Molecular & Clinical Sciences Research Institute,
Cell Biology and Genetics Research Centre,
St George's, University of London
Cranmer Terrace, London,
SW17 0RE, UK

Research Interests:

Rare diseases, cell based therapies.


  • Diagnosis delays, lack of comprehension of disease pathophysiology, poor co-ordination of care and no approved therapies are the challenges that face a majority of the rare disease community.
  • Over 7,000 rare diseases have been identified, but to date there are only around 400 licenced treatments on the market, creating a huge unmet need.
  • Currently her team are focusing on the fatal, ultra-rare disease, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Dr Bax’s research focuses on two objectives: 
i) to improve the understanding of the underlying pathogenic molecular mechanisms of rare inherited diseases and 
ii) to develop cell-based therapies for diseases with unmet needs.